| pubmed-article:18005095 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18005095 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:18005095 | lifeskim:mentions | umls-concept:C1801960 | lld:lifeskim |
| pubmed-article:18005095 | lifeskim:mentions | umls-concept:C0001511 | lld:lifeskim |
| pubmed-article:18005095 | lifeskim:mentions | umls-concept:C0948008 | lld:lifeskim |
| pubmed-article:18005095 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:18005095 | pubmed:dateCreated | 2008-7-28 | lld:pubmed |
| pubmed-article:18005095 | pubmed:abstractText | Leukocyte extravasation exacerbates tissue injury after ischaemic stroke. Vascular adhesion protein-1 (VAP-1) is an endothelial adhesion molecule with the potential capacity to guide transmigration of inflammatory cells into ischaemic brain. Moreover, VAP-1 could worsen ischaemic brain injury due to its function as a semicarbazide-sensitive amine oxidase (SSAO) producing toxic metabolites from primary amines. The purpose of this study was to elucidate these aspects of VAP-1-function in the pathogenesis of human ischaemic stroke. | lld:pubmed |
| pubmed-article:18005095 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18005095 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18005095 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18005095 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18005095 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18005095 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18005095 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18005095 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18005095 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18005095 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18005095 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:18005095 | pubmed:issn | 1365-2990 | lld:pubmed |
| pubmed-article:18005095 | pubmed:author | pubmed-author:SmithD JDJ | lld:pubmed |
| pubmed-article:18005095 | pubmed:author | pubmed-author:MononenII | lld:pubmed |
| pubmed-article:18005095 | pubmed:author | pubmed-author:JalkanenSS | lld:pubmed |
| pubmed-article:18005095 | pubmed:author | pubmed-author:LindsbergP... | lld:pubmed |
| pubmed-article:18005095 | pubmed:author | pubmed-author:AirasLL | lld:pubmed |
| pubmed-article:18005095 | pubmed:author | pubmed-author:Karjalainen-L... | lld:pubmed |
| pubmed-article:18005095 | pubmed:author | pubmed-author:KotisaariKK | lld:pubmed |
| pubmed-article:18005095 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18005095 | pubmed:volume | 34 | lld:pubmed |
| pubmed-article:18005095 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18005095 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18005095 | pubmed:pagination | 394-402 | lld:pubmed |
| pubmed-article:18005095 | pubmed:meshHeading | pubmed-meshheading:18005095... | lld:pubmed |
| pubmed-article:18005095 | pubmed:meshHeading | pubmed-meshheading:18005095... | lld:pubmed |
| pubmed-article:18005095 | pubmed:meshHeading | pubmed-meshheading:18005095... | lld:pubmed |
| pubmed-article:18005095 | pubmed:meshHeading | pubmed-meshheading:18005095... | lld:pubmed |
| pubmed-article:18005095 | pubmed:meshHeading | pubmed-meshheading:18005095... | lld:pubmed |
| pubmed-article:18005095 | pubmed:meshHeading | pubmed-meshheading:18005095... | lld:pubmed |
| pubmed-article:18005095 | pubmed:meshHeading | pubmed-meshheading:18005095... | lld:pubmed |
| pubmed-article:18005095 | pubmed:meshHeading | pubmed-meshheading:18005095... | lld:pubmed |
| pubmed-article:18005095 | pubmed:meshHeading | pubmed-meshheading:18005095... | lld:pubmed |
| pubmed-article:18005095 | pubmed:meshHeading | pubmed-meshheading:18005095... | lld:pubmed |
| pubmed-article:18005095 | pubmed:meshHeading | pubmed-meshheading:18005095... | lld:pubmed |
| pubmed-article:18005095 | pubmed:meshHeading | pubmed-meshheading:18005095... | lld:pubmed |
| pubmed-article:18005095 | pubmed:meshHeading | pubmed-meshheading:18005095... | lld:pubmed |
| pubmed-article:18005095 | pubmed:meshHeading | pubmed-meshheading:18005095... | lld:pubmed |
| pubmed-article:18005095 | pubmed:meshHeading | pubmed-meshheading:18005095... | lld:pubmed |
| pubmed-article:18005095 | pubmed:meshHeading | pubmed-meshheading:18005095... | lld:pubmed |
| pubmed-article:18005095 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18005095 | pubmed:articleTitle | Vascular adhesion protein-1 in human ischaemic stroke. | lld:pubmed |
| pubmed-article:18005095 | pubmed:affiliation | Department of Neurology, MediCity Research Laboratory, Turku University, Turku, Finland. laura.airas@utu.fi | lld:pubmed |
| pubmed-article:18005095 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18005095 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| entrez-gene:8639 | entrezgene:pubmed | pubmed-article:18005095 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:18005095 | lld:entrezgene |
